17-36486940-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 8P and 1B. PP5_Very_StrongBP4
The NM_004773.4(ZNHIT3):c.92C>T(p.Ser31Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000197 in 1,611,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004773.4 missense
Scores
Clinical Significance
Conservation
Publications
- PEHO syndromeInheritance: AR, AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- Mayer-Rokitansky-Kuster-Hauser syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ZNHIT3 | NM_004773.4 | c.92C>T | p.Ser31Leu | missense_variant | Exon 2 of 5 | ENST00000617429.5 | NP_004764.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ZNHIT3 | ENST00000617429.5 | c.92C>T | p.Ser31Leu | missense_variant | Exon 2 of 5 | 1 | NM_004773.4 | ENSP00000484687.1 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152128Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000424 AC: 104AN: 245376 AF XY: 0.000434 show subpopulations
GnomAD4 exome AF: 0.000174 AC: 254AN: 1459138Hom.: 0 Cov.: 34 AF XY: 0.000171 AC XY: 124AN XY: 725930 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000414 AC: 63AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.000645 AC XY: 48AN XY: 74436 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
PEHO syndrome Pathogenic:3
The heterozygous p.Ser31Leu variant in ZNHIT3 was identified by our study, in the compound heterozygous state, along with another likely pathogenic variant, in an individual with PEHO syndrome (PMID: 31048081). This variant has also been reported in 22 additional individuals with PEHO syndrome, segregated with disease in 4 affected relatives from 2 families (PMID: 28335020), which increases the likelihood that the p.Ser31Leu variant is pathogenic. The variant has also been reported as pathogenic by OMIM in ClinVar (Variation ID: 427725). The p.Ser31Leu variant has been identified in 0.476% (119/25006) of European (Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs148890852). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The p.Ser31Leu is located in a region of ZNHIT3 that is essential to protein folding and stability, suggesting that this variant is in a functional domain and slightly supports pathogenicity (PMID: 28335020). Additionally, animal models in zebrafish and in vitro functional studies have shown that this variant causes PEHO syndrome (PMID: 28335020). However, these types of experiments may not accurately represent biological function. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PS3, PM3, PM1_Supporting, PP1 (Richards 2015). -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at